NCT00146224 Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis Status COMPLETED Phase PHASE3
NCT00144755 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE3
NCT00144131 Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy Status COMPLETED Phase PHASE2
NCT00141921 Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00140660 ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE3
NCT00140595 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Status COMPLETED Phase PHASE3
NCT00140244 Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome Status COMPLETED Phase PHASE2
NCT00140231 Role of Leptin in the Neuroendocrine and Immune Response to Fasting Status COMPLETED Phase PHASE1/PHASE2
NCT00135317 AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies Status COMPLETED Phase PHASE3
NCT00135304 ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism Status COMPLETED Phase PHASE4
NCT00132431 START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Status COMPLETED Phase PHASE4
NCT00132418 Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders Status COMPLETED Phase PHASE4
NCT00131638 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00130117 Study of Leptin for the Treatment of Hypothalamic Amenorrhea Status COMPLETED Phase PHASE2
NCT00129896 Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00127842 REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) Status COMPLETED Phase PHASE4
NCT00125723 FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy Status COMPLETED Phase PHASE4
NCT00124111 A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer Status COMPLETED Phase PHASE2
NCT00124098 An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) Status COMPLETED Phase PHASE3